Exencial Wealth Advisors’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-4,305
| Closed | -$252K | – | 453 |
|
|
2021
Q4 | $252K | Hold |
4,305
| – | – | 0.01% | 411 |
|
|
2021
Q3 | $255K | Buy |
4,305
+30
| +0.7% | +$1.78K | 0.01% | 295 |
|
|
2021
Q2 | $371K | Sell |
4,275
-175
| -4% | -$15.2K | 0.02% | 353 |
|
|
2021
Q1 | $367K | Sell |
4,450
-1,750
| -28% | -$144K | 0.02% | 322 |
|
|
2020
Q4 | $564K | Sell |
6,200
-500
| -7% | -$45.5K | 0.04% | 234 |
|
|
2020
Q3 | $268K | Hold |
6,700
| – | – | 0.01% | 308 |
|
|
2020
Q2 | $230K | Buy |
+6,700
| New | +$230K | 0.02% | 297 |
|